$XENE Xenon Pharmaceuticals Inc. Insiders

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Xenon Pharmaceuticals Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of current and past insiders in Xenon Pharmaceuticals Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.

Xenon Pharmaceuticals Inc. Insiders

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
AYCARDI-FONSECA ERNESTOCMO00Mar 13 2020
AZAB MOHAMMADDirector63,733522,611Dec 15 2020
AZAB MOHAMMADDirector00Nov 06 2014
AZAB MOHAMMADDirector2,46920,246Jan 12 2015
Bridger GaryEVP, Research & Development00Nov 25 2014
BVF PARTNERS L P/IL10% Owner336,4682,759,038Mar 29 2018
COHEN CHARLES J.VP, Biology8,19467,191Dec 13 2018
CORRAINI KAREN G.Gen. Counsel & Corp. Secretary00Mar 19 2015
Desjardins ClarissaDirector00Jun 02 2020
EMPFIELD JAMES R.EVP, Drug Discovery10,00082,000Mar 15 2021
Evans Johnston LDirector00May 06 2015
Evans Johnston LDirector444,6553,646,171Nov 12 2014
GANNON STEVENDirector15,000123,000Jun 02 2020
GOLDBERG Y. PAULSVP, Clinical Development6,00049,200Oct 24 2017
Graham DawnDirector50,000410,000Jun 02 2020
Hayden Michael RDirector50,924417,577Jun 02 2020
Hayden Michael RDirector10,28884,362Feb 05 2015
HOLLER FRANK ADirector122,0411,000,736Jun 02 2020
MORTIMER IANPRESIDENT & CFO6,00049,200Mar 15 2021
MX Associates, LLP10% Owner00Jan 07 2015
PATOU GARYDirector100820Jun 04 2021
PATOU GARYDirector00Nov 06 2014
PATOU GARYDirector3,49728,675Jan 09 2015
PIMSTONE SIMON N.CEO210,1861,723,525Mar 15 2021
ROBIN SHERRINGTONEVP, Strategy & Innovation29,141238,956Jun 01 2021
SCHELLER RICHARD HDirector7,00057,400Sep 18 2019
STEIN EVAN A.Director4,17234,210May 04 2015
TARNOW MICHAEL MDirector74,857613,827Oct 29 2020
TARNOW MICHAEL MDirector48,583398,381Nov 12 2014
TARNOW MICHAEL MDirector53,624439,717Jan 12 2015
Von Seggern ChristopherChief Commercial Officer00Mar 15 2021
WINQUIST RAYMONDHead, Translational Research1,0008,200Aug 21 2017